Account wins from the 11/28/06 news brief

Share this article:
Wishbone-ITP won the consumer and professional advertising business for Auxilium’s prescription testosterone replacement therapy, Testim. Pacific Communications has been named agency of record for Juvederm, Allergan’s dermal filler family of products approved in June for treating facial wrinkles and folds. Pacific, which is owned by Allergan, also handles Botox Cosmetic and other physician-dispensed skincare treatments in Allergan’s facial aesthetics portfolio. Roche switched professional agencies for its top-selling hepatitis C therapy Pegasys to Omnicom’s Harrison & Star from echo Torre Lazur, part of Interpublic Group’s McCann Healthcare Worldwide. The move followed a three-way pitch among Harrison & Star, GSW and one other agency. Pegasys is the world’s best-selling treatment for chronic hepatitis C. The drug brought in $1.13 billion in revenue last year, a 17% increase over 2004.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.